Potentially inappropriate medications in the elderly: a comprehensive protocol Suzana Mimica MatanovićVera Vlahovic-Palcevski Review Article 24 February 2012 Pages: 1123 - 1138
N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients’ daytime blood pressure, and improves inflammatory status Keren Doenyas-BarakSylvia BermanShai Efrati Clinical Trial 25 February 2012 Pages: 1139 - 1146
Serum concentrations of opioids when comparing two switching strategies to methadone for cancer pain Kristin MoksnesStein KaasaOla Dale Clinical Trial 29 February 2012 Pages: 1147 - 1156
Placebo effect model in asthma clinical studies: longitudinal meta-analysis of forced expiratory volume in 1 second Xipei WangDewei ShangWei Lu Clinical Trial 02 March 2012 Pages: 1157 - 1166
A new warfarin dosing algorithm including VKORC1 3730 G > A polymorphism: comparison with results obtained by other published algorithms Michela CiniCristina LegnaniGualtiero Palareti Pharmacogenetics 19 February 2012 Pages: 1167 - 1174
Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals Renli TengPatrick MitchellKathleen Butler Pharmacokinetics and Disposition 25 February 2012 Pages: 1175 - 1182
A prospective analysis of the preventability of adverse drug reactions reported in Sweden Henrik LövborgLinda Ring ErikssonStaffan Hägg Pharmacoepidemiology and Prescription 19 February 2012 Pages: 1183 - 1189
Objective assessment of nonadherence and unknown co-medication in hospitalized patients Florentine CarowKarin RiegerWalter E. Haefeli Pharmacoepidemiology and Prescription 22 February 2012 Pages: 1191 - 1199
Effect of statins on total cholesterol concentrations and cardiovascular outcomes in patients with diabetes mellitus: a population-based cohort study Xia ShengMichael J. MurphyLi Wei Pharmacoepidemiology and Prescription 22 February 2012 Pages: 1201 - 1208
Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients Daniela FritzAlessandro CeschiStefan Russmann Pharmacoepidemiology and Prescription 29 February 2012 Pages: 1209 - 1219
Buccal and intranasal lorazepam clinical pharmacokinetics: can it adequately compete with intravenous lorazepam in pediatric care patients? Nuggehally R. Srinivas Letter to the Editors 25 February 2012 Pages: 1221 - 1223
Interpreting randomised trials evaluating newer agents or interferon in multiple sclerosis Andrea MessoriFabiola Del SantoSabrina Trippoli Letter to the Editors 29 February 2012 Pages: 1225 - 1226
Indirect comparisons of treatment effects in multiple sclerosis Maria Pia SormaniAlessio Signori Letter to the Editors 29 February 2012 Pages: 1227 - 1228
Comments on article by Kinsella et al. published in the November 2011 issue IndumathiSteven A. Dkhar Letter to the Editors 01 March 2012 Pages: 1229 - 1230
Pharmacokinetic and safety of raltegravir in pregnancy Leonardo CrociMichele TrezziCesira Nencioni Letter to the Editors 01 March 2012 Pages: 1231 - 1232